VIRIDIAN THERAPEUTICS, INC.\DE (VRDN)
Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock
Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock
The Andersons, Inc. Reports First Quarter Results
Standard BioTools Reports First Quarter 2026 Financial Results
OnKure Therapeutics Reports First Quarter 2026 Financial Results
IMAX to Present at J.P. Morgan’s 2026 Global Technology, Media and Communications Conference
LeMaitre Q1 2026 Financial Results
Coupang Announces Results for First Quarter 2026
Arista Networks, Inc. Reports First Quarter 2026 Financial Results
Amwell® Announces Results for First Quarter 2026
Visa to Participate in Upcoming Investor Conferences